|
Issue |
Title |
|
No 2 (2014) |
RETRACTED: Dosage forms and their role in modern homeopathic practice |
Abstract
PDF (Rus)
|
E. I. Sakanyan, N. D. Bunyatyan, M. N. Lyakina, N. S. Tereshina, T. B. Shemeryankina, N. A. Postoyuk |
|
No 2 (2013) |
RETRACTED: International experience in drug names assessment: European Medicines Agency |
Abstract
PDF (Rus)
|
A. N. Mironov, I. V. Sakaeva, V. V. Dudchenko, L. V. Korneeva, A. N. Yavorsky |
|
No 1 (2011) |
RETRACTED: Opportunities of the method «Budget impact analysis» for performing pharmacoeconomic research |
Abstract
PDF (Rus)
|
V. V. Ryazhenov, S. G. Gorokhova, N. D. Bunyatyan |
|
Vol 11, No 4 (2021) |
Antibiotic Dosing in Chronic Kidney Disease |
Abstract
PDF (Rus)
|
N. D. Bunyatyan, V. I. Petrov, O. V. Shatalova, A. V. Ponomareva, A. Yu. Ryazanova, V. S. Gorbatenko, A. S. Gerasimenko, E. A. Sokova |
|
Vol 11, No 4 (2021) |
Current Approaches to Demonstration of Therapeutic Equivalence of Locally-Acting Gastrointestinal Drugs |
Abstract
PDF (Rus)
|
E. V. Gorbunova, D. V. Goryachev, T. E. Gorskaya, A. N. Bogdanov |
|
Vol 11, No 4 (2021) |
Advanced Therapy Medicines Based on Oncolytic Viruses (Part II: Development and Authorisation of IMLYGIC®) |
Abstract
PDF (Rus)
|
E. V. Melnikova, O. A. Rachinskaya, V. A. Merkulov |
|
Vol 11, No 3 (2021) |
Advanced Therapy Medicines Based on Oncolytic Viruses (Part I: Development and Authorisation of Products in China) |
Abstract
PDF (Rus)
|
E. V. Melnikova, O. A. Rachinskaya, V. A. Merkulov |
|
Vol 11, No 3 (2021) |
Selection of Endpoints for Clinical Studies of Ophthalmic Drugs |
Abstract
PDF (Rus)
|
M. O. Komarova |
|
Vol 11, No 3 (2021) |
Experimental Cell Line Models for Nephrotoxicity Screening |
Abstract
PDF (Rus)
|
I. A. Mazerkina, V. A. Evteev, A. B. Prokofiev, O. V. Muslimova, E. Yu. Demchenkova |
|
Vol 11, No 3 (2021) |
Analysis of Vitamin A in Multivitamin Products |
Abstract
PDF (Rus)
|
A. S. Alekseeva, T. B. Shemeryankina, M. N. Lyakina, M. S. Smirnova, E. P. Fedorova, S. D. Kakhramanova |
|
Vol 11, No 2 (2021) |
Determination of Anthracene Derivatives in Herbal Medicines |
Abstract
PDF (Rus)
|
O. V. Evdokimova, A. V. Beketova, M. N. Lyakina |
|
Vol 11, No 2 (2021) |
Recommendations on the Clinical Trial Programme for Diabetes Medicines |
Abstract
PDF (Rus)
|
I. A. Proskurina, E. A. Petraneva, D. V. Goryachev |
|
Vol 11, No 2 (2021) |
Specific Aspects and Significance of Subgroup Assessment in Confirmatory Clinical Trials |
Abstract
PDF (Rus)
|
O. I. Basova, I. V. Lysikova, O. Yu. Ivanova |
|
Vol 11, No 1 (2021) |
Comparison of Approaches to Stability Testing of Medicines in the Russian Federation and the Eurasian Economic Union |
Abstract
PDF (Rus)
|
A. I. Belanova, E. L. Kovaleva, L. I. Mit’kina |
|
Vol 11, No 1 (2021) |
Planning Bioequivalence Studies in the Context of the COVID-19 Pandemic |
Abstract
PDF (Rus)
|
D. P. Romodanovsky, A. L. Khokhlov, D. V. Goryachev |
|
Vol 10, No 4 (2020) |
Thrombopoietin Receptor Agonists: Clinical Use and Evaluation of Treatment Efficacy |
Abstract
PDF (Rus)
|
A. G. Solodovnikov, E. Yu. Sorokina, E. I. Morkovin |
|
Vol 10, No 4 (2020) |
Sea Water-Based Medicines: Manufacturing Technology and Standardisation |
Abstract
PDF (Rus)
|
N. S. Tereshina, M. N. Lyakina, O. A. Naumova |
|
Vol 10, No 4 (2020) |
Current Requirements for the Degree of Fineness of Herbal Substances and Herbal Medicinal Products |
Abstract
PDF (Rus)
|
E. L. Kovaleva, V. V. Shelestova, L. N. Frolova, O. V. Bondarenko, O. B. Nikolaeva, V. Yu. Kuteynikov |
|
Vol 10, No 3 (2020) |
Marketing Authorisation Based on Incomplete Clinical Data: International Experience and Prospects |
Abstract
PDF (Rus)
|
D. V. Goryachev, N. E. Uvarova, G. V. Shukshina |
|
Vol 10, No 3 (2020) |
Preclinical in vivo Neurotoxicity Studies of Drug Candidates |
Abstract
PDF (Rus)
|
N. V. Eremina, L. G. Kolik, R. U. Ostrovskaya, A. D. Durnev |
|
Vol 10, No 3 (2020) |
β-Lactam Antibiotics—Drug-Drug Interaction Mediated by Organic Anion Transporters OAT1 and OAT3 |
Abstract
PDF (Rus)
|
I. A. Mazerkina, V. A. Evteev, A. B. Prokofiev, O. V. Muslimova, E. Yu. Demchenkova |
|
Vol 10, No 3 (2020) |
Harmonisation of Russian and Foreign Pharmacopoeial Standard Terms |
Abstract
PDF (Rus)
|
Z. S. Shprakh |
|
Vol 10, No 2 (2020) |
Therapeutic Drug Monitoring, CYP2C9 Genotyping and Phenotyping in the Treatment of Diabetes with Glibenclamide Products |
Abstract
PDF (Rus)
|
G. I. Gorodetskaya, V. V. Arkhipov, E. S. Melnikov, T. A. Rodina |
|
Vol 10, No 2 (2020) |
Anti-Tumour Drugs: Planning Preclinical Efficacy and Safety Studies |
Abstract
PDF (Rus)
|
O, A. Bezborodova, A. A. Pankratov, E. R. Nemtsova, Yu. B. Venediktova, M. S. Vorontsova, G. N. Engalycheva, R. D. Syubaev |
|
Vol 10, No 2 (2020) |
Current Approaches to the Abnormal Toxicity Test |
Abstract
PDF (Rus)
|
N. P. Neugodova, E. O. Stepanyuk, G. A. Sapozhnikova, E. I. Sakanyan, M. S. Ryabtseva |
|
Vol 10, No 2 (2020) |
Current Approaches to Planning and Conducting Clinical Trials of Medicinal Products for the Treatment of Crohn's Disease |
Abstract
PDF (Rus)
|
А. N. Bogdanov, E. V. Gorbunova, D. V. Goryachev, E. V. Petraneva |
|
Vol 10, No 1 (2020) |
Comparison of the Nomenclatures of Herbal Substances Used in the Russian and Foreign Pharmacopoeial Texts |
Abstract
PDF (Rus)
|
L. N. Frolova, E. L. Kovaleva, E. I. Sakanyan, V. Yu. Kuteynikov, V. V. Shelestova, M. A. Cheremisina |
|
Vol 10, No 1 (2020) |
Dose Selection in Preclinical Studies: Cross-Species Dose Conversion |
Abstract
PDF (Rus)
|
E. V. Shekunova, M. A. Kovaleva, M. N. Makarova, V. G. Makarov |
|
Vol 10, No 1 (2020) |
Quality Control of Ethyl Alcohol Used as a Medicinal Product |
Abstract
PDF (Rus)
|
Yu. V. Olefir, A. Yu. Khubieva, E. L. Kovaleva, L. I. Mit’kina, A. A. Struzhkova, E. V. Savin |
|
Vol 9, No 4 (2019) |
Interchangeability of Essential Phospholipid Products |
Abstract
PDF (Rus)
|
N. D. Bunyatyan, B. B. Sysuev, L. L. Nikolaeva |
|
Vol 9, No 4 (2019) |
Regulatory Approaches to the Development Programme for Medicines Used to Treat Infectious Diseases |
Abstract
PDF (Rus)
|
I. V. Lysikova, O. I. Basova |
|
Vol 9, No 4 (2019) |
The main issues of quality assurance of radiopharmaceuticals |
Abstract
PDF (Rus)
|
G. E. Kodina, A. O. Malysheva |
|
Vol 9, No 4 (2019) |
Quality Standards of Preclinical Pharmacological Studies |
Abstract
PDF (Rus)
|
G. N. Engalycheva, R. D. Syubaev, D. V. Goryachev |
|
Vol 9, No 3 (2019) |
Nonspecific Impurities in Pharmaceutical Substances: Characteristics of Test Methods |
Abstract
PDF (Rus)
|
Yu. R. Biglova, N. V. Gadasina, T. N. Bokovikova, E. L. Kovaleva, S. A. Nemykina, T. V. Morgunova, T. V. Masterkova, L. A. Stronova, E. P. Gernikova |
|
Vol 9, No 3 (2019) |
Evaluation of Coenzyme Q10 Redox Status as a Biomarker of Oxidative Stress |
Abstract
PDF (Rus)
|
O. A. Goroshko, L. M. Krasnykh, V. G. Kukes, V. I. Zozina |
|
Vol 9, No 3 (2019) |
Problems of Establishing Limits for Arsenic Content in Brown Algae and Brown Algae-Containing Medicinal Products |
Abstract
PDF (Rus)
|
V. M. Shchukin, A. A. Erina, E. A. Lisman, O. A. Vaganova |
|
Vol 9, No 3 (2019) |
Clinical Pharmacology Aspects of Some Tocolytic Drugs Used in Pregnant Women at Risk of Preterm Birth |
Abstract
PDF (Rus)
|
E. A. Sоkоvа, R. A. Chilova, O. A. Demidova, K. O. Akopov |
|
Vol 9, No 2 (2019) |
Development of a New Dosage Form of Herbal Medicinal Products |
Abstract
PDF (Rus)
|
N. P. Rukavitsyna, E. I. Sakanyan, O. V. Evdokimova |
|
Vol 9, No 2 (2019) |
Experience of Practical Application of the Automated Information System «Document Management of Scientific and Technical Product Deliveries» |
Abstract
PDF (Rus)
|
D. P. Andreev, A. V. Kozlovich, S. S. Andreev, I. G. Rakov |
|
Vol 9, No 2 (2019) |
Current Requirements for Information Content and Graphic Design of a Medicinal Product Package |
Abstract
PDF (Rus)
|
L. I. Mit'kina, Anastasiya K. Ericheva |
|
Vol 9, No 2 (2019) |
New Anticonvulsants: Interchangeability Issues and the Use of Generic Anticonvulsants in Clinical Practice |
Abstract
PDF (Rus)
|
V. V. Arkhipov, E. A. Sokova, G. I. Gorodetskaya, O. A. Demidova, T. V. Aleksandrova |
|
Vol 9, No 2 (2019) |
Assessment of the Feasibility of Therapeutic Equivalence Studies |
Abstract
PDF (Rus)
|
D. V. Goryachev, N. E. Uvarova |
|
Vol 9, No 2 (2019) |
Comparative Studies of Biosimilar Medicinal Products |
Abstract
PDF (Rus)
|
O. B. Talibov |
|
Vol 9, No 2 (2019) |
Modern Approaches to Determination of the Biological Activity of Insulin and Its Analogues |
Abstract
PDF (Rus)
|
T. A. Batuashvili, L. V. Simutenko, P. V. Shadrin, N. P. Neugodova |
|
Vol 9, No 1 (2019) |
Criteria for evaluation of clinical efficacy of anticancer medicines |
Abstract
PDF (Rus)
|
A. V. Tikhomirova |
|
Vol 9, No 1 (2019) |
Approaches to clinical development of combination medicines in the Russian Federation and the Eurasian Economic Union in view of the requirements of the current legislation |
Abstract
PDF (Rus)
|
A. V. Dobrovolskiy |
|
Vol 9, No 1 (2019) |
Planning a programme of pre-authorisation clinical trials of medicines for the treatment of chronic hepatitis C |
Abstract
PDF (Rus)
|
A. I. Gubenko, N. N. Eremenko |
|
Vol 9, No 1 (2019) |
Post-approval variations to dossiers for vaccines: analysis of regulatory and methodological approaches used in the Russian Federation and abroad |
Abstract
PDF (Rus)
|
V. A. Shevtsov, Yu. V. Olefir, V. A. Merkulov, V. P. Bondarev, I. N. Indikova, E. E. Evreinova, A. V. Rukavishnikov, L. M. Khantimirova, D. V. Gorenkov |
|
Vol 9, No 1 (2019) |
Conceptualisation of an information analytical database of reference standards |
Abstract
PDF (Rus)
|
D. P. Andreev, A. V. Kozlovich |
|
Vol 9, No 1 (2019) |
Regulatory requirements of the European Medicines Agency for evaluation of bioequivalence of modified-release medicinal products |
Abstract
PDF (Rus)
|
D. P. Romodanovsky, N. N. Eremenko, D. V. Goryachev |
|
Vol 8, No 4 (2018) |
Interchangeability of Fluconazole Drugs |
Abstract
PDF (Rus)
|
N. D. Bunyatyan, B. B. Sysuev, E. A. Sokova, V. A. Evteev |
|
Vol 8, No 4 (2018) |
Planning of a Clinical Data Registry for Basic Anti-Inflammatory Drugs for the Treatment of Rheumatoid Arthritis |
Abstract
PDF (Rus)
|
D. V. Goryachev, M. Yu Telnykh |
|
Vol 8, No 4 (2018) |
Planning and Evaluation of Bioequivalence Studies of Enalapril Products |
Abstract
PDF (Rus)
|
D. P. Romodanovsk, A. L. Khokhlov, A. E. Miroshnikov |
|
Vol 8, No 4 (2018) |
Criteria for Assessment of Cognitive Impairment in Clinical Trials |
Abstract
PDF (Rus)
|
A. P. Solovyova, D. V. Goryachev, V. V. Arkhipov |
|
Vol 8, No 4 (2018) |
Current Requirements for and Approaches to Dosing in Animal Studies |
Abstract
PDF (Rus)
|
A. V. Rybakova, M. N. Makarova, A. E. Kukharenko, A. S. Vichare, F. R. Rueffer |
|
Vol 8, No 3 (2018) |
CURRENT REQUIREMENTS FOR THE QUALITY OF HERBAL MEDICINAL PRODUCTS |
Abstract
PDF (Rus)
|
E. I. Sakanyan, E. L. Kovaleva, L. N. Frolova, V. V. Shelestova |
|
Vol 8, No 3 (2018) |
ANALYSIS OF THE RESULTS OF USING AMINO, AMIDE AND NITRILE SORBENTS IN HYDROPHILIC INTERACTION LIQUID CHROMATOGRAPHY |
Abstract
PDF (Rus)
|
A. S. Osipov, O. A. Popova, S. G. Larionova |
|
Vol 8, No 3 (2018) |
X-RAY POWDER DIFFRACTION IN QUALITY CONTROL OF MEDICINES |
Abstract
PDF (Rus)
|
V. S. Kuzmin, V. V. Chernyshev, A. I. Luttseva |
|
Vol 8, No 3 (2018) |
PLANNING AND EVALUATION OF BIOEQUIVALENCE STUDIES OF ATAZANAVIR PRODUCTS |
Abstract
PDF (Rus)
|
N. E. Uvarova, N. N. Eremenko, G. V. Ramenskaya, D. V. Goryachev |
|
Vol 8, No 3 (2018) |
EXPERT EVALUATION OF PRECLINICAL STUDIES OF PRIMARY AND SECONDARY PHARMACODYNAMICS OF MEDICINES |
Abstract
PDF (Rus)
|
G. N. Engalycheva, R. D. Subaev, D. V. Gorachev, Yu. V. Olefir |
|
Vol 8, No 3 (2018) |
MODERN ASPECTS OF HOMEOPATHIC MEDICINES STANDARDISATION |
Abstract
PDF (Rus)
|
E. I. Sakanyan, N. S. Tereshina, M. N. Lyakina |
|
Vol 8, No 2 (2018) |
SPECIFIC ASPECTS OF BENEFIT-RISK EVALUATION OF HERBAL MEDICINAL PRODUCTS: ANALYSIS OF REGISTRATION DOSSIERS |
Abstract
PDF (Rus)
|
N. G. Olenina, N. S. Mikheeva, N. M. Krutikova |
|
Vol 8, No 2 (2018) |
PRINCIPLES OF STATISTICAL EVALUATION OF BIOEQUIVALENCE STUDIES IN THE CONTEXT OF CURRENT REGULATORY REQUIREMENTS AND LEGAL ACTS |
Abstract
PDF (Rus)
|
D. P. Romodanovsky, D. V. Goryachev, A. P. Solovieva, N. N. Eremenko |
|
Vol 8, No 2 (2018) |
INFORMATION SYSTEM FOR EXPERT EVALUATION OF MEDICINES INTERCHANGEABILITY |
Abstract
PDF (Rus)
|
D. P. Andreev, E. M. Rychikhina, A. V. Kozlovich, B. K. Romanov |
|
Vol 8, No 2 (2018) |
CREATION OF AN INFORMATION SYSTEM FOR MANAGING THE ACTIVITIES OF TESTING LABORATORIES OF AN EXPERT INSTITUTION IN THE SPHERE OF MEDICINAL PRODUCTS CIRCULATION |
Abstract
PDF (Rus)
|
K. А. Koshechkin |
|
Vol 8, No 2 (2018) |
EFFICACY AND SAFETY OF ANTIEPILEPTIC DRUGS DURING PREGNANCY: PHARMACOGENETIC ASPECTS |
Abstract
PDF (Rus)
|
E. A. Sоkоvа, V. V. Arkhipov, R. A. Chilova, O. A. Demidova, G. F. Proklova, T. V. Pikuza |
|
Vol 8, No 2 (2018) |
DRUGS CONTAINING SNAKE VENOM: HISTORY OF DEVELOPMENT, NOMENCLATURE, IDENTIFICATION |
Abstract
PDF (Rus)
|
V. E Grigorieva, O. V Gunar, N. G Sakhno, G. M Bulgakova, N. V Molchan |
|
Vol 8, No 1 (2018) |
PRECLINICAL AND CLINICAL ASPECTS OF THE DEVELOPMENT OF BIOMEDICAL CELL PRODUCTS |
Abstract
PDF (Rus)
|
A. V. Tikhomirova, D. V. Goryachev, V. A. Merkulov, I. V. Lysikova, A. I. Gubenko, A. I. Zebrev, А. P. Solovieva, D. P. Romodanovsky, E. V. Melnikova |
|
Vol 8, No 1 (2018) |
GOOD DISTRIBUTION PRACTICE: MODERNISATION OF THE MEDICINES DISTRIBUTION SYSTEM IN RUSSIA |
Abstract
PDF (Rus)
|
E. V. Yakovleva |
|
Vol 8, No 1 (2018) |
EXPERT APPROACHES TO EQUIVALENCE EVALUATION OF DRUGS — ANALOGUES OF ENDOGENOUS COMPOUNDS AS CONSISTENT WITH THE RUSSIAN LEGISLATION AND INTERNATIONAL LAW |
Abstract
PDF (Rus)
|
D. P. Romodanovsky, D. V. Goryachev, A. P. Solovieva, I. V. Kokin, N. N. Eremenko |
|
Vol 8, No 1 (2018) |
NON-BIOLOGICAL COMPLEX DRUGS CONCEPT IN GENERIC DRUGS DEVELOPMENT |
Abstract
PDF (Rus)
|
D. V. Goryachev, Yu. V. Chernova, N. E. Uvarova |
|
Vol 8, No 1 (2018) |
ANALGESIC POTENTIAL OF PURINE RECEPTOR AGONISTS AND B VITAMINS IN THE TREATMENT OF DIABETIC POLYNEUROPATHY |
Abstract
PDF (Rus)
|
O. A. Demidova, E. V. Shikh |
|
Vol 7, No 3 (2017) |
Modern approaches to the assessment of orally inhaled products bioequivalence |
Abstract
PDF (Rus)
|
E. S. Petrova, D. V. Goryachev, M. V. Petrov |
|
Vol 7, No 3 (2017) |
Planning and evaluation of bioequivalence studies of rosuvastatin drug products |
Abstract
PDF (Rus)
|
D. P. Romodanovsky, D. V. Goryachev |
|
Vol 7, No 3 (2017) |
Clinical pharmacology aspects of drugs for hiv-infected pregnant women |
Abstract
PDF (Rus)
|
E. A. Sokova, I. A. Mazerkina, O. A. Demidova, T. V. Aleksandrova |
|
Vol 7, No 3 (2017) |
Regulatory approaches to evaluation of biosimilars for treatment of rheumatic diseases |
Abstract
PDF (Rus)
|
D. V. Goryachev, M. Yu. Telnykh, N. D. Bunyatyan |
|
Vol 7, No 4 (2017) |
Interchangeability of glibenclamide-containing drugs |
Abstract
PDF (Rus)
|
G. I. Gorodetskaya, E. V. Shikh, M. V. Zhuravleva, S. Yu. Serebrova, E. A. Sokova, O. V. Muslimova, T. V. Aleksandrova, I. A. Mazerkina, S. G. Rudnev |
|
Vol 7, No 4 (2017) |
Prospects of using C3435T polymorphism in the ABCB1 gene encoding P-glycoprotein in personalised medicine |
Abstract
PDF (Rus)
|
R. E. Kazakov, V. A. Evteev, O. V. Muslimova, I. A. Mazerkina, E. Yu. Demchenkova, E. V. Shikh |
|
Vol 7, No 4 (2017) |
Rome IV criteria of functional gastrointestinal diseases in evaluation of drugs interchangeability: through the eyes of a clinical pharmacologist |
Abstract
PDF (Rus)
|
S. Yu. Serebrova, A. B. Prokofiev, M. V. Zhuravleva, N. N. Eremenko |
|
Vol 7, No 4 (2017) |
Metrological aspects of expert evaluation of medicinal products’ quality |
Abstract
PDF (Rus)
|
A. A. Turundaeva, Yu. V. Olefir, A. I. Lutseva, N. N. Gromova, E. A. Mamashina |
|
Vol 7, No 4 (2017) |
Pharmacogenetic testing in the treatment of type 2 diabetes with sulfonylurea drugs |
Abstract
PDF (Rus)
|
G. I. Gorodetskaya, V. G. Kukes, S. A. Belkov, R. E. Kazakov, S. Yu. Serebrova, O. V. Muslimova, T. A. Rodina, A. A. Aleksandrov |
|
Vol 7, No 4 (2017) |
Analysis of international experience in creating reference standards databases |
Abstract
PDF (Rus)
|
A. V. Kozlovich, V. N. Kotikov, L. V. Korsun, S. A. Kalinichev |
|
1 - 82 of 82 Items |
|